No Data
No Data
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Announces Target Price $370
Express News | Treace Medical Concepts Inc - Expects Adjusted Ebitda Breakeven in 2025
Express News | Treace Medical Concepts Inc - Expects 2024 Adjusted Ebitda to Improve 50% Compared to 2023
Treace Files Patent Infringement and Unfair Competition Suit Against Stryker to Protect Lapiplasty Bunion Technology
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $383
RBC Capital Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $386
No Data
No Data
steven smith38 : hummmmmm. have to do fracture on this one almost tap out.